These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15482675)

  • 1. [In vitro antibacterial activity of cefdinir against isolates of respiratory tract pathogens in children].
    Lu Q; Zhang H; Che DT; Li WH
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):697-700. PubMed ID: 15482675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefdinir: in vitro activity study and effect of human serum.
    García-Rodríguez JA; Trujillano-Martín I; García-Sánchez JE
    Drugs Exp Clin Res; 1993; 19(2):51-8. PubMed ID: 8223142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of cefdinir (FK482) and ten other antibiotics against gram-positive and gram-negative bacteria isolated from adult and pediatric patients.
    Sultan T; Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(2):80-91. PubMed ID: 8131638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].
    Xiao YH; Gao L; Li Y; Lü Y; Liu J; Liu Y
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1867-71. PubMed ID: 15631795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
    Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
    Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
    J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in-vitro activity of cefdinir (FK482), a new oral cephalosporin.
    Wise R; Andrews JM; Thornber D
    J Antimicrob Chemother; 1991 Aug; 28(2):239-48. PubMed ID: 1778855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistance surveillance of common community respiratory pathogens isolated in China, 2002 - 2003].
    Wang H; Yu YS; Liu Y; Li HY; Hu BJ; Sun ZY; Chen MJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Mar; 27(3):155-60. PubMed ID: 15130324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activities of cefditoren against respiratory pathogens isolated from children in Japan.
    Seki H; Kasahara Y; Ohta K; Ohta K; Saikawa Y; Sumita R; Yachie A; Fujita Si SI; Koizumi S
    J Infect Chemother; 1999 Mar; 5(1):16-20. PubMed ID: 11810485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of cefdinir (CI-983; FK-482) against staphylococci, gram-negative bacilli and respiratory tract pathogens.
    Scriver SR; Willey BM; Low DE; Simor AE
    Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):646-52. PubMed ID: 1396778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries.
    Lee MY; Ko KS; Oh WS; Park S; Lee JY; Baek JY; Suh JY; Peck KR; Lee NY; Song JH
    Int J Antimicrob Agents; 2006 Jul; 28(1):14-8. PubMed ID: 16777383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
    Bauernfeind A; Jungwirth R
    Infection; 1991; 19(5):353-62. PubMed ID: 1800377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibacterial activity of oral Cephems against various clinically isolated strains].
    Oshiro T; Fukutomi Y; Takayanagi M; Kusaba K; Nagasawa Z; Aoki Y; Nagayama A
    Jpn J Antibiot; 2003 Dec; 56(6):681-90. PubMed ID: 15007876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011.
    Flamm RK; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):437-42. PubMed ID: 24582578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
    Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity in vitro of cefaclor, a new oral cephalosporin.
    Meyers BR; Hirschman SZ
    J Clin Pharmacol; 1978; 18(2-3):85-90. PubMed ID: 624778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative kill and growth rates determined with cefdinir and cefaclor and with Streptococcus pneumoniae and beta-lactamase-producing Haemophilus influenzae.
    Yourassowsky E; Van der Linden MP; Crokaert F
    Antimicrob Agents Chemother; 1992 Jan; 36(1):46-9. PubMed ID: 1590698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial activity of FK482, a new orally active cephalosporin.
    Mine Y; Kamimura T; Watanabe Y; Tawara S; Matsumoto Y; Shibayama F; Kikuchi H; Takaya T; Kuwahara S
    J Antibiot (Tokyo); 1988 Dec; 41(12):1873-87. PubMed ID: 3264828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.